Symbols / HROW $39.14 -0.79% Harrow, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NGM
HROW Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; BYOOVIZ, a LUCENTIS biosimilar indicated for the treatment of patients with Neovascular (Wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV); VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; OPUVIZ, an EYLEA biosimilar indicated for the treatment of patients with Wet AMD, macular edema following RVO, diabetic macular edema (DME), and diabetic retinopathy (DR); MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.

Fundamentals
Scroll to Statements
Market Cap 1.46B Enterprise Value 1.65B Income -5.14M Sales 272.30M Book/sh 1.41 Cash/sh 2.02
Dividend Yield — Payout 0.00% Employees 373 IPO — P/E — Forward P/E 14.39
PEG — P/S 5.35 P/B 27.78 P/C — EV/EBITDA 33.70 EV/Sales 6.04
Quick Ratio 1.93 Current Ratio 2.20 Debt/Eq 483.72 LT Debt/Eq — EPS (ttm) -0.14 EPS next Y 2.72
EPS Growth -10.30% Revenue Growth 33.30% Earnings 2026-05-07 ROA 4.84% ROE -8.47% ROIC —
Gross Margin 75.05% Oper. Margin 17.50% Profit Margin -1.89% Shs Outstand 37.23M Shs Float 27.35M Short Float 23.20%
Short Ratio 6.39 Short Interest — 52W High 54.85 52W Low 21.12 Beta 0.31 Avg Volume 713.38K
Volume 548.14K Target Price $68.12 Recom Strong_buy Prev Close $39.45 Price $39.14 Change -0.79%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$68.13
Mean price target
2. Current target
$39.14
Latest analyst target
3. DCF / Fair value
$21.85
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$39.14
Low
$59.00
High
$91.00
Mean
$68.13

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-17 reit BTIG Buy → Buy $63
2026-04-07 reit B. Riley Securities Buy → Buy $65
2026-03-19 reit HC Wainwright & Co. Buy → Buy $70
2026-03-18 reit BTIG Buy → Buy $63
2026-03-04 main Cantor Fitzgerald Overweight → Overweight $91
2026-03-04 main HC Wainwright & Co. Buy → Buy $70
2025-11-12 main Ladenburg Thalmann Buy → Buy $66
2025-11-12 main HC Wainwright & Co. Buy → Buy $69
2025-10-01 reit B. Riley Securities Buy → Buy $74
2025-09-29 main Lake Street Buy → Buy $70
2025-09-29 reit HC Wainwright & Co. Buy → Buy $64
2025-09-29 reit BTIG Buy → Buy $63
2025-09-24 reit BTIG Buy → Buy $63
2025-09-23 main B. Riley Securities Buy → Buy $70
2025-09-23 main Craig-Hallum Buy → Buy $64
2025-09-23 reit BTIG Buy → Buy $63
2025-08-14 main BTIG Buy → Buy $63
2025-08-13 main HC Wainwright & Co. Buy → Buy $64
2025-07-11 init Cantor Fitzgerald — → Overweight $76
2025-06-10 init William Blair — → Outperform —
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-04 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 198,572 $39.15 $7,846,426
2026-02-27 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 5,000 $54.18 $270,900
2026-01-06 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 20,000 $53.35 $1,066,914
2025-12-12 BAUM MARK L Chief Executive Officer — 180,000 $3.95 $711,000
2025-12-12 BOLL ANDREW R President — 60,000 $3.95 $237,000
2025-07-21 BAUM MARK L Chief Executive Officer — 600,000 $7.87 $4,722,000
2025-06-10 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 30,204 $30.37 $923,827
2025-06-04 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 4,796 $30.02 $144,024
2025-05-13 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 15,000 $25.90 $391,904
2025-04-03 BAUM MARK L Chief Executive Officer — 762,300 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
272.30
+36.41%
199.61
+53.32%
130.19
+46.95%
88.59
Operating Revenue
271.91
+36.90%
198.62
+69.11%
117.45
+32.57%
88.59
Cost Of Revenue
67.93
+37.95%
49.24
+24.23%
39.64
+56.17%
25.38
Reconciled Cost Of Revenue
67.93
+37.95%
49.24
+24.23%
39.64
+56.17%
25.38
Gross Profit
204.37
+35.91%
150.37
+66.06%
90.55
+43.25%
63.21
Operating Expense
173.85
+23.04%
141.29
+57.44%
89.74
+46.41%
61.29
Research And Development
20.94
+71.22%
12.23
+83.85%
6.65
+118.10%
3.05
Selling General And Administration
152.91
+18.48%
129.06
+55.33%
83.09
+42.66%
58.24
Total Expenses
241.79
+26.90%
190.54
+47.27%
129.38
+49.27%
86.68
Operating Income
30.52
+236.25%
9.07
+1018.99%
0.81
-57.74%
1.92
Total Operating Income As Reported
30.52
+245.90%
8.82
+1946.87%
0.43
-77.54%
1.92
EBITDA
42.49
+112.41%
20.00
+100.95%
9.95
+420.89%
-3.10
Normalized EBITDA
50.24
+114.45%
23.43
+84.36%
12.71
+333.28%
-5.45
Reconciled Depreciation
19.68
+35.36%
14.54
+17.80%
12.34
+236.70%
3.67
EBIT
22.81
+317.34%
5.47
+329.09%
-2.39
+64.74%
-6.77
Total Unusual Items
-7.75
-126.34%
-3.42
-24.37%
-2.75
-217.40%
2.35
Total Unusual Items Excluding Goodwill
-7.75
-126.34%
-3.42
-24.37%
-2.75
-217.40%
2.35
Special Income Charges
-7.75
-2963.24%
-0.25
+95.67%
-5.84
-211.14%
5.26
Other Special Charges
7.75
—
5.46
—
Impairment Of Capital Assets
0.00
-100.00%
0.25
-33.42%
0.38
0.00
Net Income
-5.14
+70.60%
-17.48
+28.39%
-24.41
-73.30%
-14.09
Pretax Income
-1.37
+92.10%
-17.32
+26.95%
-23.71
-69.22%
-14.01
Net Non Operating Interest Income Expense
-24.18
-6.12%
-22.79
-6.86%
-21.32
-194.37%
-7.24
Interest Expense Non Operating
24.18
+6.12%
22.79
+6.86%
21.32
+194.37%
7.24
Net Interest Income
-24.18
-6.12%
-22.79
-6.86%
-21.32
-194.37%
-7.24
Interest Expense
24.18
+6.12%
22.79
+6.86%
21.32
+194.37%
7.24
Other Income Expense
-7.70
-113.44%
-3.61
-12.89%
-3.20
+63.19%
-8.69
Other Non Operating Income Expenses
0.05
+125.41%
-0.18
+58.33%
-0.44
-535.29%
0.10
Gain On Sale Of Security
—
-3.17
-202.55%
3.09
+206.11%
-2.91
Tax Provision
3.77
+2242.24%
0.16
-77.03%
0.70
+834.67%
0.07
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-1.63
-126.34%
-0.72
-24.37%
-0.58
-217.40%
0.49
Net Income Including Noncontrolling Interests
-5.14
+70.60%
-17.48
+28.39%
-24.41
-73.30%
-14.09
Net Income From Continuing Operation Net Minority Interest
-5.14
+70.60%
-17.48
+28.39%
-24.41
-73.30%
-14.09
Net Income From Continuing And Discontinued Operation
-5.14
+70.60%
-17.48
+28.39%
-24.41
-73.30%
-14.09
Net Income Continuous Operations
-5.14
+70.60%
-17.48
+28.39%
-24.41
-73.30%
-14.09
Minority Interests
—
—
—
—
Normalized Income
0.98
+106.66%
-14.78
+33.55%
-22.24
-39.51%
-15.94
Net Income Common Stockholders
-5.14
+70.60%
-17.48
+28.39%
-24.41
-73.30%
-14.09
Diluted EPS
-0.14
+71.43%
-0.49
+34.67%
-0.75
-47.06%
-0.51
Basic EPS
-0.14
+71.43%
-0.49
+34.67%
-0.75
-47.06%
-0.51
Basic Average Shares
36.76
+3.11%
35.65
+9.30%
32.62
+18.09%
27.62
Diluted Average Shares
36.76
+3.11%
35.65
+9.30%
32.62
+18.09%
27.62
Diluted NI Availto Com Stockholders
-5.14
+70.60%
-17.48
+28.39%
-24.41
-73.30%
-14.09
Earnings From Equity Interest
—
—
0.00
+100.00%
-11.13
Gain On Sale Of PPE
—
—
0.00
-100.00%
5.26
Preferred Stock Dividends
—
—
—
—
Total Other Finance Cost
—
—
—
7.24
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
399.48
+2.70%
388.97
+24.60%
312.16
+98.35%
157.38
Current Assets
211.75
+11.65%
189.65
+35.97%
139.48
+17.95%
118.26
Cash Cash Equivalents And Short Term Investments
72.93
+54.35%
47.25
-42.91%
82.77
-18.74%
101.86
Cash And Cash Equivalents
72.93
+54.35%
47.25
-36.23%
74.08
-23.04%
96.27
Cash Financial
72.93
+54.35%
47.25
-36.23%
74.08
-23.04%
96.27
Other Short Term Investments
—
0.00
-100.00%
8.68
+55.32%
5.59
Receivables
110.89
-4.89%
116.60
+219.55%
36.49
+471.21%
6.39
Accounts Receivable
110.89
-4.71%
116.37
+220.93%
36.26
+480.27%
6.25
Gross Accounts Receivable
137.92
+1.03%
136.52
+165.05%
51.51
+632.88%
7.03
Allowance For Doubtful Accounts Receivable
-27.03
-34.16%
-20.15
-32.15%
-15.25
-1857.12%
-0.78
Inventory
13.52
+26.36%
10.70
-1.52%
10.87
+66.14%
6.54
Raw Materials
6.96
+29.77%
5.36
-2.10%
5.48
+47.75%
3.71
Work In Process
1.04
+20.75%
0.86
+1488.89%
0.05
+42.11%
0.04
Finished Goods
5.53
+23.36%
4.48
-16.00%
5.34
+90.84%
2.80
Prepaid Assets
12.28
+5.01%
11.69
+62.42%
7.20
+114.61%
3.35
Current Deferred Assets
—
0.00
-100.00%
0.41
0.00
Other Current Assets
2.13
-37.60%
3.41
+94.52%
1.75
+1385.59%
0.12
Total Non Current Assets
187.73
-5.81%
199.32
+15.43%
172.68
+341.44%
39.12
Net PPE
11.04
-10.13%
12.29
+19.23%
10.31
-6.30%
11.00
Gross PPE
23.27
-0.15%
23.30
+14.35%
20.38
+1.59%
20.06
Accumulated Depreciation
-12.22
-10.99%
-11.01
-9.35%
-10.07
-11.16%
-9.06
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
—
—
6.79
-9.69%
7.51
Machinery Furniture Equipment
2.13
-0.98%
2.15
-4.74%
2.26
+22.78%
1.84
Other Properties
13.71
-1.10%
13.86
+22.13%
11.35
-3.59%
11.77
Leases
7.43
+1.91%
7.29
+7.68%
6.77
+4.99%
6.45
Goodwill And Other Intangible Assets
176.69
-5.53%
187.03
+15.18%
162.38
+520.49%
26.17
Goodwill
0.33
+0.00%
0.33
+0.00%
0.33
+0.00%
0.33
Other Intangible Assets
176.36
-5.54%
186.70
+15.22%
162.04
+527.18%
25.84
Investments And Advances
—
—
—
0.00
Long Term Equity Investment
—
—
—
0.00
Non Current Deferred Assets
—
—
0.00
-100.00%
1.95
Total Liabilities Net Minority Interest
347.39
+8.67%
319.67
+32.23%
241.75
+85.77%
130.14
Current Liabilities
96.30
+5.43%
91.34
+85.11%
49.34
+164.83%
18.63
Payables And Accrued Expenses
94.63
+4.21%
90.80
+87.36%
48.46
+172.33%
17.80
Payables
35.35
-8.79%
38.76
+80.93%
21.42
+232.67%
6.44
Accounts Payable
35.35
-8.79%
38.76
+80.93%
21.42
+232.67%
6.44
Current Accrued Expenses
59.27
+13.90%
52.04
+92.46%
27.04
+138.10%
11.36
Current Debt And Capital Lease Obligation
0.89
+78.47%
0.50
-38.34%
0.81
+11.48%
0.72
Current Capital Lease Obligation
0.89
+78.47%
0.50
-38.34%
0.81
+11.48%
0.72
Current Deferred Liabilities
0.79
+1690.91%
0.04
-41.33%
0.07
-33.63%
0.11
Current Deferred Revenue
0.79
+1690.91%
0.04
-41.33%
0.07
-33.63%
0.11
Total Non Current Liabilities Net Minority Interest
251.09
+9.97%
228.33
+18.67%
192.41
+72.55%
111.51
Long Term Debt And Capital Lease Obligation
251.09
+9.97%
228.33
+18.67%
192.41
+72.55%
111.51
Long Term Debt
243.18
+10.77%
219.54
+18.10%
185.88
+78.44%
104.17
Long Term Capital Lease Obligation
7.91
-10.09%
8.79
+34.76%
6.52
-11.02%
7.33
Stockholders Equity
52.45
-24.70%
69.65
-1.57%
70.77
+156.45%
27.59
Common Stock Equity
52.45
-24.70%
69.65
-1.57%
70.77
+156.45%
27.59
Capital Stock
0.04
+5.71%
0.04
+0.00%
0.04
+16.67%
0.03
Common Stock
0.04
+5.71%
0.04
+0.00%
0.04
+16.67%
0.03
Share Issued
37.23
+4.51%
35.62
+1.29%
35.17
+17.61%
29.90
Ordinary Shares Number
37.23
+4.51%
35.62
+1.29%
35.17
+17.61%
29.90
Additional Paid In Capital
208.93
-5.46%
221.00
+8.00%
204.63
+49.31%
137.06
Retained Earnings
-156.52
-3.39%
-151.38
-13.05%
-133.90
-22.29%
-109.49
Minority Interest
-0.35
+0.00%
-0.35
+0.00%
-0.35
+0.00%
-0.35
Total Equity Gross Minority Interest
52.09
-24.83%
69.30
-1.58%
70.41
+158.48%
27.24
Total Capitalization
295.63
+2.23%
289.19
+12.68%
256.65
+94.77%
131.77
Working Capital
115.45
+17.44%
98.31
+9.06%
90.14
-9.53%
99.63
Invested Capital
295.63
+2.23%
289.19
+12.68%
256.65
+94.77%
131.77
Total Debt
251.98
+10.12%
228.83
+18.43%
193.22
+72.16%
112.23
Net Debt
170.26
-1.18%
172.29
+54.11%
111.80
+1314.47%
7.90
Capital Lease Obligations
8.79
-5.35%
9.29
+26.73%
7.33
-9.00%
8.05
Net Tangible Assets
-124.24
-5.85%
-117.38
-28.13%
-91.61
-6524.26%
1.43
Tangible Book Value
-124.24
-5.85%
-117.38
-28.13%
-91.61
-6524.26%
1.43
Duefrom Related Parties Current
0.00
-100.00%
0.23
+0.00%
0.23
+64.03%
0.14
Interest Payable
6.50
+156.03%
2.54
+28.31%
1.98
+57.74%
1.25
Investmentsin Subsidiariesat Cost
—
—
—
0.00
Non Current Accrued Expenses
—
—
2.71
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
43.86
+297.57%
-22.20
-678.18%
3.84
+125.22%
1.71
Cash Flow From Continuing Operating Activities
43.86
+297.57%
-22.20
-678.18%
3.84
+125.22%
1.71
Net Income From Continuing Operations
-5.14
+70.60%
-17.48
+28.39%
-24.41
-73.30%
-14.09
Depreciation Amortization Depletion
19.68
+35.36%
14.54
+17.80%
12.34
+236.70%
3.67
Depreciation
2.09
-4.00%
2.17
+21.87%
1.78
-14.57%
2.09
Amortization Cash Flow
17.59
+42.28%
12.36
+17.12%
10.56
+569.01%
1.58
Depreciation And Amortization
19.68
+35.36%
14.54
+17.80%
12.34
+236.70%
3.67
Amortization Of Intangibles
17.59
+42.28%
12.36
+17.12%
10.56
+569.01%
1.58
Other Non Cash Items
4.05
-3.69%
4.21
+2.64%
4.10
+423.91%
0.78
Stock Based Compensation
12.50
-29.04%
17.62
+12.25%
15.70
+96.84%
7.97
Provisionand Write Offof Assets
0.47
+290.00%
0.12
-63.86%
0.33
+309.88%
0.08
Asset Impairment Charge
0.00
-100.00%
0.25
-33.42%
0.38
0.00
Operating Gains Losses
12.12
+282.25%
3.17
+24.79%
2.54
-71.31%
8.86
Gain Loss On Sale Of PPE
0.01
0.00
-100.00%
0.17
+103.24%
-5.19
Change In Working Capital
0.18
+100.41%
-44.63
-525.45%
-7.13
-28.14%
-5.57
Change In Receivables
5.01
+106.24%
-80.23
-164.41%
-30.34
-1531.40%
-1.86
Changes In Account Receivables
5.01
+106.24%
-80.23
-164.41%
-30.34
-1531.40%
-1.86
Change In Inventory
-2.82
-1809.70%
0.17
+103.81%
-4.33
-86.14%
-2.32
Change In Prepaid Assets
0.92
+115.22%
-6.07
-7.53%
-5.65
-68.57%
-3.35
Change In Payables And Accrued Expense
-3.67
-108.84%
41.54
+25.06%
33.22
+1677.42%
1.87
Change In Accrued Expense
0.94
-76.87%
4.05
+183.93%
1.43
+52.24%
0.94
Change In Payable
-4.61
-112.29%
37.50
+17.94%
31.80
+3307.82%
0.93
Change In Account Payable
-4.61
-112.29%
37.50
+17.94%
31.80
+3307.82%
0.93
Change In Other Working Capital
0.74
+2500.00%
-0.03
+18.42%
-0.04
-139.18%
0.10
Investing Cash Flow
-5.46
+83.54%
-33.16
+78.26%
-152.55
-8652.32%
-1.74
Cash Flow From Continuing Investing Activities
-5.46
+83.54%
-33.16
+78.26%
-152.55
-8652.32%
-1.74
Net PPE Purchase And Sale
-0.89
+44.39%
-1.59
-9.25%
-1.46
+43.12%
-2.57
Purchase Of PPE
-0.89
+44.39%
-1.59
-9.25%
-1.46
+43.78%
-2.60
Sale Of PPE
—
—
0.00
-100.00%
0.03
Capital Expenditure
-1.10
+97.15%
-38.67
+74.65%
-152.55
-1862.60%
-7.77
Capital Expenditure Reported
—
—
—
0.00
Net Investment Purchase And Sale
0.00
-100.00%
5.51
0.00
0.00
Sale Of Investment
0.00
-100.00%
5.51
0.00
0.00
Net Business Purchase And Sale
-4.36
0.00
0.00
—
Purchase Of Business
-4.36
0.00
0.00
—
Gain Loss On Sale Of Business
4.36
0.00
0.00
—
Net Intangibles Purchase And Sale
-0.21
+99.42%
-37.08
+75.46%
-151.09
-2819.11%
-5.18
Purchase Of Intangibles
-0.21
+99.42%
-37.08
+75.46%
-151.09
-2819.11%
-5.18
Net Other Investing Changes
—
—
—
6.00
Financing Cash Flow
-12.72
-144.60%
28.53
-77.45%
126.53
+133.70%
54.14
Cash Flow From Continuing Financing Activities
-12.72
-144.60%
28.53
-77.45%
126.53
+133.70%
54.14
Net Issuance Payments Of Debt
13.47
-54.76%
29.78
+2632.11%
1.09
-96.56%
31.72
Issuance Of Debt
244.38
+720.60%
29.78
-51.05%
60.84
+91.69%
31.74
Repayment Of Debt
-230.90
0.00
+100.00%
-59.75
-331844.44%
-0.02
Long Term Debt Issuance
244.38
+720.60%
29.78
-51.05%
60.84
+91.69%
31.74
Long Term Debt Payments
-230.90
0.00
+100.00%
-59.75
-331844.44%
-0.02
Net Long Term Debt Issuance
13.47
-54.76%
29.78
+2632.11%
1.09
-96.56%
31.72
Net Common Stock Issuance
0.00
0.00
-100.00%
138.07
+509.45%
22.66
Cash Dividends Paid
—
—
—
0.00
Repurchase Of Capital Stock
—
—
—
0.00
Proceeds From Stock Option Exercised
0.47
-57.93%
1.11
+192.88%
0.38
-40.97%
0.64
Net Other Financing Charges
-26.66
-1028.83%
-2.36
+81.85%
-13.01
-1385.50%
-0.88
Changes In Cash
25.68
+195.69%
-26.84
-20.97%
-22.18
-141.01%
54.10
Beginning Cash Position
47.25
-36.23%
74.08
-23.04%
96.27
+128.31%
42.17
End Cash Position
72.93
+54.35%
47.25
-36.23%
74.08
-23.04%
96.27
Free Cash Flow
42.76
+170.24%
-60.88
+59.06%
-148.71
-2350.77%
-6.07
Interest Paid Supplemental Data
18.72
-9.11%
20.59
+9.04%
18.89
+191.47%
6.48
Income Tax Paid Supplemental Data
0.09
-75.13%
0.37
0.00
-100.00%
0.07
Common Stock Issuance
0.00
0.00
-100.00%
138.07
+509.45%
22.66
Earnings Losses From Equity Investments
0.00
-100.00%
3.17
+202.55%
-3.09
-122.01%
14.05
Issuance Of Capital Stock
0.00
0.00
-100.00%
138.07
+509.45%
22.66
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Dividend Paid
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Payments
—
—
—
0.00
Sale Of Business
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category